Medscape January 10, 2025
Researchers at the University of Oxford have reported results of a new blood test designed to detect multiple types of cancer, including in early stages. The test, named TriOx, uses machine learning and advanced DNA analysis to identify cancer when it is most difficult to diagnose.
Liquid biopsy technology has become a focus of research in recent years as a minimally invasive alternative to existing diagnostic tests. Although liquid biopsies show promise for detecting multiple cancers, those currently available only examine one or two features of the cancer DNA, limiting their effectiveness. Furthermore, these tests face challenges due to high false positive rates in asymptomatic individuals.
DNA Analysis and Machine Learning
TriOx employs TET-assisted pyridine borane sequencing (TAPS) combined with...
Today's Sponsors
Today's Sponsor